Meningitis, Meningococcal
"Meningitis, Meningococcal" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A fulminant infection of the meninges and subarachnoid fluid by the bacterium NEISSERIA MENINGITIDIS, producing diffuse inflammation and peri-meningeal venous thromboses. Clinical manifestations include FEVER, nuchal rigidity, SEIZURES, severe HEADACHE, petechial rash, stupor, focal neurologic deficits, HYDROCEPHALUS, and COMA. The organism is usually transmitted via nasopharyngeal secretions and is a leading cause of meningitis in children and young adults. Organisms from Neisseria meningitidis serogroups A, B, C, Y, and W-135 have been reported to cause meningitis. (From Adams et al., Principles of Neurology, 6th ed, pp689-701; Curr Opin Pediatr 1998 Feb;10(1):13-8)
| Descriptor ID |
D008585
|
| MeSH Number(s) |
C01.252.200.500.550 C01.252.400.625.549.449 C10.228.228.180.500.750 C10.228.614.280.505
|
| Concept/Terms |
Meningitis, Meningococcal, Serogroup W-135- Meningitis, Meningococcal, Serogroup W-135
- Serogroup W135, Meningococcal Meningitis
- Meningitis, Meningococcal, Serogroup W135
- Meningococcal Meningitis, Serogroup W135
- Meningococcal Meningitis, Serogroup W-135
- Meningococcal Meningitis, Serogroup W 135
- Serogroup W-135, Meningococcal Meningitis
- Serogroup W 135, Meningococcal Meningitis
|
Below are MeSH descriptors whose meaning is more general than "Meningitis, Meningococcal".
Below are MeSH descriptors whose meaning is more specific than "Meningitis, Meningococcal".
This graph shows the total number of publications written about "Meningitis, Meningococcal" by people in this website by year, and whether "Meningitis, Meningococcal" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 2001 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2013 | 1 | 0 | 1 |
| 2015 | 0 | 1 | 1 |
| 2017 | 1 | 0 | 1 |
| 2018 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Meningitis, Meningococcal" by people in Profiles.
-
Vaccine Update: Recent Progress With Novel Vaccines, and New Approaches to Safety Monitoring and Vaccine Shortage. J Clin Pharmacol. 2018 10; 58 Suppl 10:S123-S139.
-
Serogroup B Meningococcal Disease Vaccine Recommendations at a University, New Jersey, USA, 2016. Emerg Infect Dis. 2017 05; 23(5):867-869.
-
Structural, Functional, and Immunogenic Insights on Cu,Zn Superoxide Dismutase Pathogenic Virulence Factors from Neisseria meningitidis and Brucella abortus. J Bacteriol. 2015 Dec; 197(24):3834-47.
-
Human Infant Memory B Cell and CD4+ T Cell Responses to HibMenCY-TT Glyco-Conjugate Vaccine. PLoS One. 2015; 10(7):e0133126.
-
Altered neutrophil counts at diagnosis of invasive meningococcal infection in children. Pediatr Infect Dis J. 2013 Oct; 32(10):1070-2.
-
Children with bacterial meningitis presenting to the emergency department during the pneumococcal conjugate vaccine era. Acad Emerg Med. 2008 Jun; 15(6):522-8.
-
Prevalence of factor H-binding protein variants and NadA among meningococcal group B isolates from the United States: implications for the development of a multicomponent group B vaccine. J Infect Dis. 2007 May 15; 195(10):1472-9.
-
Clinical predictors for hearing loss in children with bacterial meningitis. Arch Otolaryngol Head Neck Surg. 2006 Sep; 132(9):941-5.
-
[Microbial diagnosis with PCR will become clinically beneficial with a faster analysis]. Lakartidningen. 2004 Apr 22; 101(17):1488-92.
-
Alopecia areata occurring in sisters after administration of rifampicin. J Am Acad Dermatol. 2001 Jan; 44(1):142-3.